PremiumCompany AnnouncementsLilly Targets China’s Obesity Market With New Phase 3 Oral Orforglipron Trial16h agoLLY
PremiumCompany AnnouncementsLilly’s Brenipatide Steps Into Phase 3: A New Long-Term Play in Depression Care16h agoLLY
PremiumMarket NewsNvidia Stock (NVDA): 5-Star Analyst Sees a $230 Billion Catalyst in 202716h agoAAPLNVDA
PremiumStock Analysis & Ideas‘This Flaw Is Being Ignored,’ Says Investor About Nvidia Stock16h agoNVDA
PremiumMarket NewsNvidia (NVDA) Accelerates Stockholder Returns and Promises There’s More to Come17h agoNVDA